Zim Laboratories Ltd.(IN:ZIMLAB)
₹147.95-0.20 (-0.13%)
IN:ZIMLAB
Zim Laboratories Ltd. financials statements
₹147.95
At close:-0.20 (-0.13%)
Want to see IN:ZIMLAB full AI Analyst Report?
Zim Laboratories Ltd. (ZIMLAB) Ratios
0 Followers
Zim Laboratories Ltd. Ratios
IN:ZIMLAB's free cash flow for Q2 2027 was ₹0.00. For the 2027 fiscal year, IN:ZIMLAB's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.45 | 1.39 | 1.43 | 1.72 | 1.45 |
| Quick Ratio | 0.96 | 0.87 | 0.92 | 1.24 | 0.94 |
| Cash Ratio | 0.13 | 0.01 | 0.06 | 0.06 | 0.02 |
| Solvency Ratio | 0.11 | 0.15 | 0.16 | 0.30 | 0.18 |
| Operating Cash Flow Ratio | 0.19 | 0.25 | 0.10 | 0.34 | 0.34 |
| Short-Term Operating Cash Flow Coverage | 0.45 | 0.57 | 0.23 | 1.10 | 1.52 |
| Net Current Asset Value | ₹ 325.75M | ₹ 115.22M | ₹ 195.72M | ₹ 497.15M | ₹ 462.18M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.23 | 0.25 | 0.25 | 0.18 | 0.16 |
| Debt-to-Equity Ratio | 0.43 | 0.47 | 0.47 | 0.31 | 0.30 |
| Debt-to-Capital Ratio | 0.30 | 0.32 | 0.32 | 0.24 | 0.23 |
| Long-Term Debt-to-Capital Ratio | 0.12 | 0.14 | 0.13 | 0.11 | 0.10 |
| Financial Leverage Ratio | 1.82 | 1.87 | 1.87 | 1.70 | 1.94 |
| Debt Service Coverage Ratio | 0.25 | 0.52 | 0.50 | 1.17 | 0.96 |
| Interest Coverage Ratio | 0.44 | 1.76 | 15.86 | 5.57 | 2.74 |
| Debt to Market Cap | 0.42 | 0.27 | 0.23 | 0.17 | 0.09 |
| Interest Debt Per Share | 28.40 | 26.55 | 24.34 | 13.87 | 12.62 |
| Net Debt to EBITDA | 3.95 | 2.34 | 2.24 | 0.95 | 1.10 |
| Profitability Margins | |||||
| Gross Profit Margin | 16.69% | 19.51% | 50.60% | 22.68% | 50.50% |
| EBIT Margin | 1.53% | 7.86% | 8.03% | 10.22% | 8.84% |
| EBITDA Margin | 6.95% | 13.23% | 12.37% | 14.60% | 13.69% |
| Operating Profit Margin | 1.53% | 5.36% | 29.88% | 7.80% | 6.79% |
| Pretax Profit Margin | 2.22% | 4.81% | 6.43% | 8.87% | 6.36% |
| Net Profit Margin | 1.58% | 3.25% | 4.69% | 6.13% | 4.40% |
| Continuous Operations Profit Margin | 1.58% | 3.25% | 4.69% | 6.13% | 4.40% |
| Net Income Per EBT | 71.09% | 67.55% | 72.95% | 69.11% | 69.15% |
| EBT Per EBIT | 144.91% | 89.84% | 21.53% | 113.75% | 93.70% |
| Return on Assets (ROA) | 1.08% | 2.58% | 3.86% | 7.15% | 4.26% |
| Return on Equity (ROE) | 1.97% | 4.82% | 7.22% | 12.20% | 8.28% |
| Return on Capital Employed (ROCE) | 1.62% | 6.56% | 38.21% | 13.47% | 11.47% |
| Return on Invested Capital (ROIC) | 0.93% | 3.55% | 22.21% | 8.04% | 6.77% |
| Return on Tangible Assets | 1.17% | 2.77% | 4.07% | 7.46% | 4.39% |
| Earnings Yield | 1.97% | 2.97% | 3.66% | 6.94% | 2.66% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.39 | 3.50 | 3.55 | 4.04 | 3.38 |
| Payables Turnover | 4.22 | 4.33 | 2.91 | 5.29 | 1.99 |
| Inventory Turnover | 3.28 | 3.48 | 2.23 | 5.74 | 2.14 |
| Fixed Asset Turnover | 1.72 | 1.85 | 2.04 | 3.28 | 3.09 |
| Asset Turnover | 0.68 | 0.79 | 0.82 | 1.17 | 0.97 |
| Working Capital Turnover Ratio | 4.91 | 5.62 | 4.95 | 5.44 | 5.70 |
| Cash Conversion Cycle | 132.52 | 124.95 | 140.78 | 85.06 | 94.78 |
| Days of Sales Outstanding | 107.79 | 104.39 | 102.81 | 90.43 | 107.88 |
| Days of Inventory Outstanding | 111.27 | 104.81 | 163.38 | 63.62 | 170.42 |
| Days of Payables Outstanding | 86.54 | 84.25 | 125.42 | 68.98 | 183.52 |
| Operating Cycle | 219.06 | 209.20 | 266.20 | 154.05 | 278.29 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 7.50 | 8.46 | 3.34 | 7.83 | 10.10 |
| Free Cash Flow Per Share | -1.54 | 0.07 | -11.83 | 0.31 | 6.97 |
| Dividend Paid and CapEx Coverage Ratio | 0.83 | 1.01 | 0.22 | 1.04 | 3.20 |
| Capital Expenditure Coverage Ratio | 0.83 | 1.01 | 0.22 | 1.04 | 3.23 |
| Operating Cash Flow Coverage Ratio | 0.29 | 0.35 | 0.15 | 0.62 | 0.92 |
| Operating Cash Flow to Sales Ratio | 0.10 | 0.11 | 0.04 | 0.10 | 0.15 |
| Free Cash Flow Yield | -2.56% | 0.09% | -12.23% | 0.43% | 6.22% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 50.64 | 33.62 | 27.33 | 14.41 | 37.55 |
| Price-to-Sales (P/S) Ratio | 0.80 | 1.09 | 1.28 | 0.88 | 1.65 |
| Price-to-Book (P/B) Ratio | 1.00 | 1.62 | 1.97 | 1.76 | 3.11 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -39.04 | 1146.10 | -8.18 | 234.65 | 16.08 |
| Price-to-Operating Cash Flow Ratio | 8.03 | 9.94 | 28.96 | 9.22 | 11.10 |
| Price-to-Earnings Growth (PEG) Ratio | -0.97 | -1.14 | -0.93 | 0.21 | 0.38 |
| Enterprise Value Multiple | 15.48 | 10.60 | 12.61 | 7.00 | 13.17 |
| Enterprise Value | 3.97B | 5.25B | 5.73B | 4.08B | 5.96B |
| EV to EBITDA | 15.48 | 10.60 | 12.61 | 7.00 | 13.17 |
| EV to Sales | 1.07 | 1.40 | 1.56 | 1.02 | 1.80 |
| EV to Free Cash Flow | -52.42 | 1470.71 | -9.95 | 271.66 | 17.55 |
| EV to Operating Cash Flow | 10.78 | 12.75 | 35.22 | 10.68 | 12.12 |
| Tangible Book Value Per Share | 51.78 | 45.19 | 44.35 | 38.23 | 33.90 |
| Shareholders’ Equity Per Share | 60.37 | 51.84 | 49.01 | 41.12 | 36.06 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.29 | 0.32 | 0.27 | 0.31 | 0.31 |
| Revenue Per Share | 75.26 | 76.88 | 75.44 | 81.79 | 67.88 |
| Net Income Per Share | 1.19 | 2.50 | 3.54 | 5.01 | 2.99 |
| Tax Burden | 0.71 | 0.68 | 0.73 | 0.69 | 0.69 |
| Interest Burden | 1.45 | 0.61 | 0.80 | 0.87 | 0.72 |
| Research & Development to Revenue | 0.05 | 0.06 | 0.05 | 0.05 | 0.05 |
| SG&A to Revenue | 0.11 | 0.18 | 0.03 | 0.03 | 0.04 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 6.31 | 2.29 | 0.94 | 1.08 | 2.34 |
Currency in INR

